Registered entities
Avalo Therapeutics, Inc.
Reg. No. 45-0705648United States
Avalo Therapeutics, Inc.
Reg. No. 598472United States
Cerecor, Inc.
Reg. No. 450705648United States
Innovation
15 patent families (3 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace slowing. Cited 448 times.
| Year | Filings |
|---|---|
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 12 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 2 |
Investor mix
8 investors on record; lead investors include Commodore Capital, TCG Crossover.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 50% |
| Private equity | 1 | 13% |
| Other / undisclosed | 3 | 38% |